Moderna Files 2025 Proxy Statement: Executive Compensation Details

TL;DR

Moderna's proxy statement is out, detailing exec pay and board stuff for 2024. Check it for shareholder votes.

AI Summary

Moderna, Inc. filed its Definitive Proxy Statement (DEF 14A) on March 11, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, board of directors, and other corporate governance matters. Key information includes compensation details for Named Executive Officers (NEOs) and Non-PEO NEOs, as well as equity awards granted and their year-end fair values.

Why It Matters

This filing provides shareholders with crucial information about how executive compensation is structured and approved, impacting company performance and shareholder value.

Risk Assessment

Risk Level: medium — Proxy statements can reveal information about executive compensation, potential conflicts of interest, or shareholder proposals that could impact the company's stock price.

Key Numbers

• 20250311 — Filing Date (Date the DEF 14A was filed with the SEC)
• 20250430 — Report Period End Date (Conformed period of report for the filing)
• 2024-12-31 — Fiscal Year End (Moderna's fiscal year end)

Key Players & Entities

• Moderna, Inc. (company) — Filer of the DEF 14A
• 325 BINNEY STREET (address) — Moderna's business and mailing address
• CAMBRIDGE (location) — City of Moderna's headquarters
• MA (location) — State of Moderna's headquarters
• 02142 (zip_code) — Zip code of Moderna's headquarters
• Moderna Therapeutics, Inc. (company) — Former company name

FAQ

From the Filing

0001308179-25-000082.txt : 20250311 0001308179-25-000082.hdr.sgml : 20250311 20250311160718 ACCESSION NUMBER: 0001308179-25-000082 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 128 CONFORMED PERIOD OF REPORT: 20250430 FILED AS OF DATE: 20250311 DATE AS OF CHANGE: 20250311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 25727606 BUSINESS ADDRESS: STREET 1: 325 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 325 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 DEF 14A 1 mrna-20250310.htm DEFINITIVE PROXY STATEMENT mrna-20250310 0001682852 DEF 14A FALSE iso4217:USD 0001682852 2024-01-01 2024-12-31 0001682852 2023-01-01 2023-12-31 0001682852 2022-01-01 2022-12-31 0001682852 2021-01-01 2021-12-31 0001682852 2020-01-01 2020-12-31 0001682852 mrna:DeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsOfTheSummaryCompensationTableMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:DeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsOfTheSummaryCompensationTableMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:IncreaseDecreaseForTheInclusionOfRule402vEquityValuesMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:IncreaseDecreaseForTheInclusionOfRule402vEquityValuesMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:FairValueAtVestingOfEquityAwardsGrantedAndVestedInTheFiscalYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:FairValueAtVestingOfEquityAwardsGrantedAndVestedInTheFiscalYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueOfPriorYearsEquityAwardsThatVestedDuringTheYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueOfPriorYearsEquityAwardsThatVestedDuringTheYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueOfPriorYearsEquityAwardsThatForfeitedDuringTheYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001682852 mrna:ChangeInFairValueOfPriorYearsEquityAwardsThatForfeitedDuringTheYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001682852 1 2024-01-01 2024-12-31 0001682852 2 2024-01-01 2024-12-31 0001682852 3 2024-01-01 2024-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.14a-12 MODERNA INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): ☑ No fee required ☐ Fee paid previousl